Angiodynamics Inc. ANGO
Price
Full chart with drawing tools and indicators
Valuation and ratios (P/E, margins, market value)
Price charts and figures by TradingView, shown in a sealed box: it cannot read this page, but TradingView may count your visit. Prices can be delayed.
Results from SEC filings
| Revenue | $320.2M | +9% | FY ending May 31, 2026 |
|---|---|---|---|
| Gross profit | $174.9M | +11% | FY ending May 31, 2026 |
| Operating income | $-39.9M | +0% | FY ending May 31, 2026 |
| Net income | $-36.7M | -8% | FY ending May 31, 2026 |
| Earnings per share | $-0.88 | -6% | FY ending May 31, 2026 |
| Research & development | $29.4M | +12% | FY ending May 31, 2026 |
| Cash from operations | $3.1M | +130% | FY ending May 31, 2026 |
| Capital spending | $2.6M | -42% | FY ending May 31, 2026 |
| Share buybacks | $0 | -100% | FY ending May 31, 2026 |
| Dividends paid | $0 | FY ending May 31, 2014 | |
| Cash | $53.9M | -4% | FY ending May 31, 2026 |
| Long-term debt | $0 | -100% | FY ending May 31, 2024 |
| Shareholders' equity | $170.8M | -7% | FY ending May 31, 2026 |
| Shares outstanding | 42M | +2% | FY ending May 31, 2026 |
Insider trades
Last 12 months: 0 open-market buys ($0) and 1 sale ($344K) by officers, directors and big owners. These are exact: shares times the price each insider reported. Several sales by one person on one day are combined (average price).
| Insider | Trade | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| Warren Jr NighanSVP Quality and Regulatory | Sold | 23,370 | $14.72 | $344K | Jul 30, 2026 |
Other insider moves (39): pay awards, option exercises, tax withholding, gifts
| Insider | Trade | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| James C ClemmerPresident and CEO, Director | Tax withholding | 26,728 | $13.82 | $369K | Jul 22, 2026 |
| Stephen A TrowbridgeEVP and CFO | Tax withholding | 8,319 | $13.82 | $115K | Jul 22, 2026 |
| Laura PiccininiSVP International | Tax withholding | 4,506 | $13.82 | $62K | Jul 22, 2026 |
| Chad Thomas CampbellSVP/GM, Vascular Access | Tax withholding | 2,330 | $13.82 | $32K | Jul 22, 2026 |
| Warren Jr NighanSVP Quality and Regulatory | Tax withholding | 1,671 | $13.82 | $23K | Jul 22, 2026 |
| Laura PiccininiSVP International | Option exercise | 8,047 | – | – | Jul 22, 2026 |
| Warren Jr NighanSVP Quality and Regulatory | Option exercise | 5,694 | – | – | Jul 22, 2026 |
| Stephen A TrowbridgeEVP and CFO | Option exercise | 16,296 | – | – | Jul 22, 2026 |
| James C ClemmerPresident and CEO, Director | Option exercise | 52,358 | – | – | Jul 22, 2026 |
| Chad Thomas CampbellSVP/GM, Vascular Access | Option exercise | 6,466 | – | – | Jul 22, 2026 |
| James C ClemmerPresident and CEO, Director | Tax withholding | 4,223 | $13.71 | $58K | Jul 20, 2026 |
| Stephen A TrowbridgeEVP and CFO | Tax withholding | 717 | $13.71 | $9,830 | Jul 20, 2026 |
| Laura PiccininiSVP International | Tax withholding | 616 | $13.71 | $8,445 | Jul 20, 2026 |
| Chad Thomas CampbellSVP/GM, Vascular Access | Tax withholding | 359 | $13.71 | $4,922 | Jul 20, 2026 |
| Warren Jr NighanSVP Quality and Regulatory | Tax withholding | 251 | $13.71 | $3,441 | Jul 20, 2026 |
| James C ClemmerPresident and CEO, Director | Tax withholding2 fills | 12,251 | $13.51 avg | $166K | Jul 19, 2026 |
| James C ClemmerPresident and CEO, Director | Tax withholding | 10,649 | $13.51 | $144K | Jul 17, 2026 |
| Stephen A TrowbridgeEVP and CFO | Tax withholding | 3,510 | $13.51 | $47K | Jul 17, 2026 |
| Laura PiccininiSVP International | Tax withholding | 3,074 | $13.51 | $42K | Jul 17, 2026 |
| Warren Jr NighanSVP Quality and Regulatory | Tax withholding | 1,373 | $13.51 | $19K | Jul 17, 2026 |
| Chad Thomas CampbellSVP/GM, Vascular Access | Tax withholding | 1,112 | $13.51 | $15K | Jul 17, 2026 |
| James C ClemmerPresident and CEO, Director | Tax withholding | 18,588 | $14.14 | $263K | Jul 16, 2026 |
| Stephen A TrowbridgeEVP and CFO | Tax withholding | 7,840 | $14.14 | $111K | Jul 16, 2026 |
| Laura PiccininiSVP International | Tax withholding | 4,538 | $14.14 | $64K | Jul 16, 2026 |
| Chad Thomas CampbellSVP/GM, Vascular Access | Tax withholding | 2,367 | $14.14 | $33K | Jul 16, 2026 |
| Lawrence T WeissSVP, Chief Legal Officer | Tax withholding | 2,267 | $14.14 | $32K | Jul 16, 2026 |
| Warren Jr NighanSVP Quality and Regulatory | Tax withholding | 2,153 | $14.14 | $30K | Jul 16, 2026 |
| Jan Stern ReedDirector | Award | 11,887 | – | – | Jul 15, 2026 |
| Karen A LicitraDirector | Award | 11,887 | – | – | Jul 15, 2026 |
| Wesley JohnsonDirector | Award | 11,887 | – | – | Jul 15, 2026 |
| Howard W DonnellyDirector | Award | 11,887 | – | – | Jul 15, 2026 |
| Lorinda BurgessDirector | Award | 11,887 | – | – | Jul 15, 2026 |
| Eileen O'Shea AuenDirector | Award | 11,887 | – | – | Jul 15, 2026 |
| Michael E TarnoffDirector | Award | 11,887 | – | – | Jul 15, 2026 |
| Stephen A TrowbridgeEVP and CFO | Award | 53,257 | – | – | Jul 15, 2026 |
| Laura PiccininiSVP International | Award | 19,860 | – | – | Jul 15, 2026 |
| Warren Jr NighanSVP Quality and Regulatory | Award | 17,966 | – | – | Jul 15, 2026 |
| Chad Thomas CampbellSVP/GM, Vascular Access | Award | 16,081 | – | – | Jul 15, 2026 |
| Lawrence T WeissSVP, Chief Legal Officer | Award | 21,288 | – | – | Jul 15, 2026 |
Trades by members of Congress
1 member reported 1 buy and 2 sales since Jun 27, 2025. Amounts are legal ranges, not exact figures.
| Member | Trade | Amount | Traded | Reported | Owner |
|---|---|---|---|---|---|
| Debbie Wasserman Schultz D | Sold | $2,000 (exact) | Oct 20, 2025 | Oct 24, 2025 | Child |
| Debbie Wasserman Schultz D | Sold | $1,001–$15K | Jul 16, 2025 | Jul 25, 2025 | Self |
| Debbie Wasserman Schultz D | Bought | $1,001–$15K | Jun 27, 2025 | Jul 25, 2025 | Child |
Latest SEC filings
- Quarterly report 10-Q · Oct 8, 2026
- Shareholder meeting proxy DEF 14A · Oct 8, 2026
- News filing: Quarterly results, Public announcement (Reg FD) 8-K · Oct 8, 2026
- News filing: Signed a major agreement, Executive or board change 8-K · Oct 8, 2026
- Insider plans to sell 144 · Jul 30, 2026
- Annual report 10-K · Jul 14, 2026
- News filing: Quarterly results, Public announcement (Reg FD) 8-K · Jul 14, 2026
- News filing: Other news 8-K · Apr 23, 2026
- Quarterly report 10-Q · Apr 2, 2026
- News filing: Quarterly results, Public announcement (Reg FD) 8-K · Apr 2, 2026
- News filing: Executive or board change 8-K · Feb 3, 2026
- News filing: Public announcement (Reg FD) 8-K · Jan 14, 2026
- Quarterly report 10-Q · Jan 6, 2026
- News filing: Quarterly results, Public announcement (Reg FD) 8-K · Jan 6, 2026
- News filing: Shareholder vote results 8-K · Nov 12, 2025
- Quarterly report 10-Q · Oct 2, 2025
- News filing: Quarterly results, Public announcement (Reg FD) 8-K · Oct 2, 2025
- Shareholder meeting proxy DEF 14A · Sep 25, 2025
- Annual report 10-K · Jul 18, 2025
- News filing: Quarterly results, Public announcement (Reg FD) 8-K · Jul 15, 2025
- News filing: Signed a major agreement, Took on new debt 8-K · May 28, 2025
- Quarterly report 10-Q · Apr 2, 2025
- News filing: Public announcement (Reg FD) 8-K · Apr 2, 2025
- News filing: Quarterly results, Public announcement (Reg FD) 8-K · Apr 2, 2025
- News filing: Public announcement (Reg FD) 8-K · Jan 16, 2025
About Angiodynamics Inc.
Business description
- Industry
- Surgical & Medical Instruments & Apparatus
- Sector
- Industrial Applications and Services
- Headquarters
- Latham, NY
- Incorporated in
- DE
- Fiscal year ends
- May 31
- Exchange
- Nasdaq
- Filer size
- Accelerated filer
- SEC company number (CIK)
- 1275187
Company figures and insider trades: U.S. Securities and Exchange Commission (EDGAR). Congress trades: Clerk of the U.S. House of Representatives. Nebula is not affiliated with either and this page is not investment advice.